Historical salary details - Dr. Fred E. Cohen, D.Phil.,F.A.C.P.,M.D., Independent Director, Progyny Inc
Dr. Fred E. Cohen, D.Phil.,F.A.C.P.,M.D. is the Independent Director of Progyny Inc. They also hold 3 other positions in Caredx Inc, Intellia Therapeutics Inc and UroGen Pharma Ltd.
Dr. Fred E. Cohen, D.Phil.,F.A.C.P.,M.D.
Independent Director
-
Gross Remuneration
-
Current Company
Progyny Inc
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Progyny Inc | Independent Director | - | - |
| 2024 | Caredx Inc | Independent Director | - | - |
| 2024 | Intellia Therapeutics Inc | Independent Director | - | - |
| 2024 | UroGen Pharma Ltd | Independent Director | - | - |
| 2023 | Progyny Inc | Independent Director | 583.4 K | 18.0 % |
| 2023 | Intellia Therapeutics Inc | Independent Director | 452.4 K | -0.0 % |
| 2023 | Caredx Inc | Independent Director | 355.9 K | 14.2 % |
| 2023 | UroGen Pharma Ltd | Independent Director | 193.8 K | 63.5 % |
| 2023 | Kyverna Therapeutics Inc. | Independent Director | 155.1 K | - |
| 2022 | Progyny Inc | Independent Director | 494.5 K | -20.1 % |
| 2022 | Intellia Therapeutics Inc | Independent Director | 452.5 K | 14.5 % |
| 2022 | Caredx Inc | Independent Director | 311.6 K | -1.9 % |
| 2022 | UroGen Pharma Ltd | Independent Director | 118.5 K | -38.5 % |
| 2021 | Progyny Inc | Independent Director | 618.9 K | 6.1 % |
| 2021 | Intellia Therapeutics Inc | Independent Director | 395.1 K | 40.5 % |
| 2021 | Caredx Inc | Independent Director | 317.7 K | 35.4 % |
| 2021 | UroGen Pharma Ltd | Independent Director | 192.7 K | -26.6 % |
| 2021 | Veracyte Inc | Independent Director | 23.0 K | -87.3 % |
| 2020 | Progyny Inc | Independent Director | 583.4 K | 379.4 % |
| 2020 | Intellia Therapeutics Inc | Independent Director | 281.2 K | -48.8 % |
| 2020 | UroGen Pharma Ltd | Independent Director | 262.5 K | -17.4 % |
| 2020 | Caredx Inc | Independent Director | 234.6 K | -1.9 % |
| 2020 | Veracyte Inc | Independent Director | 181.2 K | -7.1 % |
| 2019 | Intellia Therapeutics Inc | Independent Director | 548.6 K | - |
| 2019 | UroGen Pharma Ltd | Independent Director | 317.7 K | -39.5 % |
| 2019 | Caredx Inc | Independent Director | 239.2 K | -1.5 % |
| 2019 | Veracyte Inc | Independent Director | 195.0 K | 98.4 % |
| 2019 | Tandem Diabetes Care Inc | - | 176.5 K | -69.3 % |
| 2019 | Progyny Inc | Independent Director | 121.7 K | - |
| 2019 | Biocryst Pharmaceuticals Inc. | Independent Director | - | - |
| 2019 | Tandem Diabetes Care Inc | Independent Director | - | - |
| 2018 | Tandem Diabetes Care Inc | Independent Director | 574.7 K | 1019.3 % |
| 2018 | UroGen Pharma Ltd | Independent Director | 525.3 K | - |
| 2018 | Caredx Inc | Independent Director | 243.0 K | 340.4 % |
| 2018 | Biocryst Pharmaceuticals Inc. | Independent Director | 132.9 K | -23.9 % |
| 2018 | Veracyte Inc | Independent Director | 98.3 K | -2.5 % |
| 2018 | Intellia Therapeutics Inc | Independent Director | - | - |
| 2018 | Progyny Inc | Independent Director | - | - |
| 2017 | Biocryst Pharmaceuticals Inc. | Independent Director | 174.7 K | 36.4 % |
| 2017 | Veracyte Inc | Independent Director | 100.9 K | 38.7 % |
| 2017 | Caredx Inc | Independent Director | 55.2 K | -45.0 % |
| 2017 | Tandem Diabetes Care Inc | Independent Director | 51.3 K | -22.1 % |
| 2017 | UroGen Pharma Ltd | Director | - | - |
| 2016 | Biocryst Pharmaceuticals Inc. | Independent Director | 128.1 K | -20.4 % |
| 2016 | Caredx Inc | Independent Director | 100.3 K | 117.4 % |
| 2016 | Veracyte Inc | Independent Director | 72.7 K | -25.9 % |
| 2016 | Tandem Diabetes Care Inc | Independent Director | 65.9 K | -51.6 % |
| 2015 | Biocryst Pharmaceuticals Inc. | Independent Director | 160.9 K | 29.0 % |
| 2015 | Tandem Diabetes Care Inc | Independent Director | 136.3 K | -28.2 % |
| 2015 | Veracyte Inc | Independent Director | 98.1 K | -19.4 % |
| 2015 | Caredx Inc | Independent Director | 46.1 K | -52.4 % |
| 2015 | IQVIA Holdings Inc | Director | - | - |
| 2014 | Tandem Diabetes Care Inc | Independent Director | 189.9 K | 7.8 % |
| 2014 | Biocryst Pharmaceuticals Inc. | Director | 124.7 K | 2.3 % |
| 2014 | Veracyte Inc | Independent Director | 121.7 K | 1559.3 % |
| 2014 | Caredx Inc | Independent Director | 97.0 K | - |
| 2014 | IQVIA Holdings Inc | Director | - | - |
| 2013 | Tandem Diabetes Care Inc | Independent Director | 176.2 K | - |
| 2013 | Biocryst Pharmaceuticals Inc. | Director | 121.9 K | - |
| 2013 | Veracyte Inc | Independent Director | 7.3 K | - |
| 2013 | IQVIA Holdings Inc | Director | - | - |
| 2013 | Caredx Inc | Independent Director | - | - |
| 2012 | Tandem Diabetes Care Inc | Independent Director | - | - |
| 2012 | Veracyte Inc | Independent Director | - | - |
| 2012 | IQVIA Holdings Inc | Director | - | - |